CD
Codexis, Inc.
CDXS · NASDAQ
$1.36 +0.74% (+$0.01)
1M -16.46%
Market Cap $152.7M
P/E Ratio -
Div. Yield -
ROE 74.36%
Piotroski F-Score Weak
3/9Valuation
59 /100
Fair P/B 4.63x
P/S 1.97x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 29.60%
Rev. growth 20.22%
FCF growth N/A
Profitability
20 /100
Weak Net margin 39.55%
Op. margin 31.23%
FCF margin 15.68%
Quality
8 /100
Poor ROE 74.36%
ROA 25.59%
Asset turnover 0.65x
Debt
29 /100
High Current ratio 3.06x
Int. coverage -22.72x
Debt/Equity 2.20x
Stability
7 /100
Unstable Rev. volatility 34.00%
EPS volatility 88.40%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na CDXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alison Moore
Employees
146
Headquarters
Redwood City
Nadcházející události
05 LIS
Earnings
Upcoming earnings report